Facing a reaction against consumer drug advertising, the pharmaceutical industry moved toward self-policing yesterday by releasing draft guidelines that endorse a period of informing doctors about new drugs before running ads for them. The guidelines, whose final wording is still being worked out, try to address growing pressure from a variety of fronts, including Capitol Hill and the American Medical Association, and even from within the industry itself. They may not satisfy consumer groups, however, who called the guidelines a gesture to placate Congress.
- read this story from The New York Times for more